prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, SPECIMENS: A. LEFT BREAST WLE NEEDLE LOC. B. SLN #1. C. SLN #2. D. RIGHT BREAST. E. SLN #3. F. ADDITIONAL SENTINEL LYMPH NODE RIGHT AXILLA. G. RIGHT AXILLARY CONTENTS LEVELS 1 &2. SPECIMEN(S): A. LEFT BREAST WLE NEEDLE LOC. B. SLN #1. C. SLN #2. D. RIGHT BREAST. E. SLN #3. F. ADDITIONAL SENTINEL LYMPH NODE RIGHT AXILLA. G. RIGHT AXILLARY CONTENTS LEVELS 1 & 2. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA-left breast: No definitive mass seen, tissue with fibrosis by Dr. to Dr. at. TPB-SLN #1: Lymph node negative for carcinoma. TPC/TPE-SLN #2 & #3: Lymph nodes positive for carcinoma. Called by Dr. to Dr at. GROSS DESCRIPTION: A. LEFT BREAST WLE NEEDLE LOC. Received fresh labeled with the patient's identification and "left breast WLE needle localization" is an. oriented (single-anterior, double-lateral, triple-superior) needle localized lumpectomy with out. radiograph. Ink code: anterior-yellow, posterior-black, medial-green, lateral-red, superior-blue, inferior-. orange. The specimen is serially sectioned into 5 sections revealing dense fibrous tissue without a. distinct mass. No tissue is procured. Entirely submitted: A1-A3: slice 1, lateral margin, perpendicular sections. A4: slice 2, anterior. A5: slice 2, posterior. A6: slice 3, anterior. A7: slice 3, posterior. A8: slice 4, anterior. A9: slice 4, posterior. A10-A11: slice 5, medial margin, perpendicular sections. B. SLN #1. Received fresh is a 3 x 0.8 X 0.5 cm lymph node, A touch prep is performed and the lymph node is. submitted entirely in cassette B1. C. SLN #2. Received fresh is a lymph node measuring 1.4 x 1.2 X 0.5 cm. One touch prep is performed and the. lymph node is submitted entirely in cassette C1. D. RIGHT BREAST. Received fresh labeled with the patient's identification and "right breast" is an oriented 678 g, 24 X 21 x. 5 cm mastectomy with 11.5 x 7 the skin ellipse and 1.7 cm everted nipple. Ink code: anterior/superior-. blue, anterior/inferior-orange, posterior-black. The specimen is serially sectioned into 12 slices from. medial to lateral with nipple and slice 5 revealing an area of dense nodular firm fibrous tissue, 10 x 8 X 4. cm, extending from the upper inner quadrant to the mid outer quadrant at is closest to the. posterior/deep margin at 1.5 cm. Representatively submitted. D1: slice 2, lower-superior anterior. D2: slice 2, upper-inferior anterior. D3-D8: slice 3, mid section submitted from superior to inferior. D9: slice 4, lower-superior anterior. D10: slice 4, lower-superior posterior. D11: slice 5, lower-superior anterior. D12: slice 5, lower-superior posterior. D13: slice 5, made anterior. D14: slice 5, mid posterior. D15: slice 5, upper-inferior anterior. D16: slice 5, upper-inferior posterior. D17: slice 6, mid superior. D18: slice 6, lower-superior posterior. D19: slice 6, upper-inferior anterior. D20: slice 6, mid inferior. D21: slice 7, mid superior. D22: slice 7, mid inferior. D23: slice 8, mid lower-superior. D24: slice 8, mid upper-inferior. D25: slice 9, mid upper-inferior. D26: slice 9, mid inferior. D27: slice 10, mid upper-inferior. D28: slice 10, mid inferior. D29: slice 11, upper-inferior posterior. D30: slice 1, mid. D31-D32: nipple, perpendicular sections. D33: skin. D34: 1 axillary lymph node. E. SLN #3. Received fresh is a lymph node, 2 x 1 X 0.5 cm. A touch prep is performed and the lymph node is. submitted entirely in cassette E1. F. ADDITIONAL SENTINEL LYMPH NODE RIGHT AXILLA. Received fresh is a piece of yellow-tan tissue 2.5 x 2.1 x 1 cm. Two lymph nodes are identified. measuring 1.4 and 1.8 cm. Lymph nodes are submitted separately in cassettes F1-F2. G. RIGHT AXILLARY CONTENTS LEVELS 1 AND 2. Received fresh is an aggregate of adipose tissue, 7 x 5 x 1.5 cm. Multiple lymph nodes are identified. ranging from 0.1 to 2.1 cm; they have a variegated pink-tan cut surface. Lymph nodes submitted as. follows: G1-G2: 4 lymph nodes each. G3: 6 lymph nodes. G4: 2 lymph nodes. G5-G8: 1 lymph node each. DIAGNOSIS: A. BREAST/LEFT, WIDE LOCAL EXCISION: USUAL DUCTAL HYPERPLASIA WITHOUT ATYPIA, MICROCALCIFICATIONS IN BENIGN DUCTS. AND FIBROCYSTIC CHANGES WITH FIBROSIS. - FOCAL FAT NECROSIS AND MILD ACUTE INFLAMMATION, NO TUMOR SEEN. B. LYMPH NODE, SENTINEL #1, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). C. LYMPH NODE, SENTINEL #2, EXCISION: - METASTATIC CARCINOMA TO ONE OF ONE LYMPH NODE (1/1),. MEASURING 0.8-CM WITH NO EXTRANODAL EXTENSION. D. BREAST, RIGHT, SIMPLE MASTECTOMY: 1 - MULTIFOCAL, INVASIVE, LOBULAR CARCINOMA, SBR GRADE 2, MEASURING 10-CM. - INVASIVE TUMOR PRESENT 2-MM FROM DEEP SURGICAL RESECTION MARGIN. - METASTATIC CARCINOMA TO ONE OF TWO AXILLARY LYMPH NODES (1/2). - SEE SYNOPTIC REPORT AND SEE NOTE. E. LYMPH NODE, SENTINEL #3, EXCISION : - METASTATIC CARCINOMA TO ONE OF ONE LYMPH NODE (1/1),. MEASURING 0.7-CM WITH FOCAL EXTRANODAL EXTENSION. F. LYMPH NODE, ADDITIONAL SENTINEL, RIGHT AXILLA, BIOPSY: - METASTATIC CARCINOMA TO ONE OF TWO LYMPH NODES (1/2). G. LYMPH NODES, RIGHT AXILLARY CONTENTS, LEVELS 1 AND 2, DISSECTION: TWENTY LYMPH NODES, NEGATIVE FOR METASTASES (0/20). NOTE: Extensive and multifocal invasive lobular carcinoma is identified. The tumor grossly measures. 10-cm. Microscopic examination reveals that the tumor extends from slice #1 to slice #8 (predominantly. in the inner half, central and subareolar region, with extension to outer quadrants. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: Right. Invasive Tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive lobular carcinoma 8520/3. Tumor size: 10cm. Tumor Site: Upper outer quadrant. Lower outer quadrant. Upper inner quadrant. Lower inner quadrant. Central. Margins: Negative. Distance from closest margin: 0.2cm. deep. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 1. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node and axillary dissection. Lymph node status: Positive 4 / 27 Extranodal extension. DCIS not present. ER/PR/HER2 Results. ER: Positive. PR: Negative. HER2: Negative by FISH. Performed on Case: HER2 by FISH performed in outside facility. Pathological staging (pTN): pT 3N2a. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: D1. ER: Positive. Allred Score: 8 = Proportion Score 5 + Intensity Score 3. PR: Negative Allred Score: 0 = Proportion Score 0 + Intensity Score 0. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score. of less than or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistry was performed using the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR. 136, 1:100) provided by. following the manufacturer S instructions. This. assay was not modified. Interpretation of the ER/PR immunohistochemical stain is guided by published. results in the medical literature, information provided by the reagent manufacturer and by internal. review of staining performance. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Right breast cancer, left abnormal imaging. Microscopic/Diagnostic Dictation:. Pathologist,. Final Review: Pathologist,. Final Review: Pathologist. Final Review: Pathologist,. Final: Pathologist,.

expanded version (tokens=2803) : 
 Histological Classification: 

Left Breast:
- Usual ductal hyperplasia without atypia.
- Fibrocystic changes with fibrosis.
- Focal fat necrosis and mild acute inflammation, no tumor seen.

Right Breast:
- Multifocal invasive lobular carcinoma, SBR grade 2, measuring 10cm.
- Invasive tumor present 2mm from deep surgical resection margin.
- Metastatic carcinoma to one of two axillary lymph nodes (1/2).
- Metastatic carcinoma to one of one lymph nodes (1/1), measuring 0.7 cm with focal extranodal extension.
- Twenty lymph nodes from right axillary contents levels 1 and 2 were negative for metastases (0/20).

Subtype: Luminal A

Description of any Necrosis: 
- Focal fat necrosis was seen in the left breast.

Tumor Infiltrating Lymphocytes: None mentioned.

Histological Grade: 
- SBR grade 2 for the invasive lobular carcinoma in the right breast.

Nuclear Grade:
- Nuclear grade 2 for the invasive lobular carcinoma in the right breast.

Lymphovascular Invasion: 
- None identified.

Calcification:
- Microcalcifications in benign ducts were seen in the left breast.

Receptor Status: 
- ER positive and PR negative for the invasive lobular carcinoma in the right breast.
- HER2 negative by FISH.

Ancillary Testing Results

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2980) : 
 The patient (unspecified) presented with usual ductal hyperplasia without atypia, fibrocystic changes with fibrosis and a focal fat necrosis in the left breast. The right side exhibited multifocal invasive lobular carcinoma (SBR grade 2), measuring 10 cm; an invasive tumor within 2-mm margin distance from deep surgical resection, metastasis in one axillary and one sentinel node each; while twenty lymph nodes in the right axillary were negative for metastases. The subtype was Luminal A. ER-positive/PR-negative, HER2-negative by FISH. No lymphovascular invasion seen.

